✦ LIBER ✦

Myositis due to Sorafenib intake in a patient with hepatocellular carcinoma

✍ Scribed by Antonio Diaz-Sanchez; Nuria Rodriguez-Salas; Teresa Aramendi; Eva Balbin

Book ID: 119229806
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 276 KB
Volume: 43
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2010.11.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Probable sorafenib-induced reversible en

Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma

✍ Erkan Dogan; Sercan Aksoy; Cagatay Arslan; Didem S. Dede; Kadri Altundag 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 107 KB

Diarrhea predicts a positive response to

Diarrhea predicts a positive response to sorafenib in patients with advanced hepatocellular carcinoma

✍ Dominik Bettinger; Michael Schultheiβ; Eva Knüppel; Robert Thimme; Hubert E. Blu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Sorafenib-induced acute localized exanth

Sorafenib-induced acute localized exanthematous pustulosis in a patient with hepatocellular carcinoma

✍ C.-P. Liang; C.-S. Yang; J.-L. Shen; Y.-J. Chen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

Pharmacokinetic interaction between sora

Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinoma

✍ Satoshi Noda, Makoto Shioya, Daiki Hira… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 237 KB

PR-104 plus sorafenib in patients with a

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma

✍ Ghassan K. Abou-Alfa; Stephan L. Chan; Chia-Chi Lin; E. Gabriela Chiorean; Randa 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 180 KB

Sorafenib therapy in patients with hepat

Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation

✍ Ian A. Rowe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi